Melanoma Prognosis Calculation:
From: | To: |
Melanoma prognosis estimates survival outcomes based on tumor characteristics including stage, thickness, and ulceration status according to AJCC (American Joint Committee on Cancer) guidelines.
The calculator uses AJCC staging criteria:
Where:
Explanation: The calculation incorporates validated prognostic factors from large melanoma studies.
Details: Accurate prognosis estimation helps guide treatment decisions, surveillance intensity, and patient counseling.
Tips: Enter tumor thickness in mm, select appropriate stage and ulceration status. All values must be valid (thickness > 0).
Q1: What's the most important prognostic factor?
A: Tumor thickness (Breslow depth) and stage are primary determinants, with ulceration being an important modifier.
Q2: How does stage affect prognosis?
A: Earlier stages (I/II) have better prognosis than advanced stages (III/IV), with 5-year survival ranging from >90% for stage I to <20% for stage IV.
Q3: Why is ulceration important?
A: Ulceration typically worsens prognosis by approximately one stage (e.g., a stage II ulcerated melanoma may have prognosis similar to stage III non-ulcerated).
Q4: Are there other important factors?
A: Yes, mitotic rate, lymph node involvement, distant metastases, and molecular markers also affect prognosis but aren't included in this basic calculator.
Q5: How often should prognosis be reassessed?
A: After any new diagnostic information (e.g., sentinel node biopsy results) or if recurrence is detected.